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Abstract
Obese individuals are at greater risk for hospitalization and death from infection with the 2009 
pandemic H1N1 influenza virus (pH1N1). In this study, diet-induced and genetic-induced obese 
mouse models were utilized to uncover potential mechanisms by which obesity increases pH1N1 
severity. High fat diet-induced and genetic-induced obese mice exhibited greater pH1N1 
mortality, lung inflammatory responses and excess lung damage despite similar levels of viral 
burden compared with lean control mice. Further, obese mice had fewer bronchoalveolar 
macrophages and regulatory T cells during infection. Obesity is inherently a metabolic disease, 
and metabolic profiling has found widespread usage in metabolic and infectious disease models 
for identifying biomarkers and enhancing understanding of complex mechanisms of disease. To 
further characterize the consequences of obesity on pH1N1 infection responses, we performed 
global liquid chromatography-mass spectrometry metabolic profiling of lung tissue and urine. An 
array of metabolites were perturbed by obesity both prior to and during infection. Uncovered 
metabolic signatures were used to identify changes in metabolic pathways that were differentially 
altered in the lungs of obese mice such as fatty acid, phospholipid, and nucleotide metabolism. 
Taken together, obesity induces distinct alterations in the lung metabolome, perhaps contributing 
to aberrant pH1N1 immune responses.
Introduction
The triple reassortant H1N1 influenza virus (pH1N1) caused the first pandemic of the 21st 
century in 2009, and this strain continues to circulate and contribute to seasonal influenza 
epidemics globally (1, 2). Although infection with the pH1N1 strain typically results in 
relatively mild, uncomplicated symptoms, a number of epidemiological investigations have 
identified obesity as an independent risk factor for hospitalization and death to pH1N1 (3–
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6). More than 500 million individuals are obese (body mass index ≥30kg/m2) globally (7), 
and thus, understanding the mechanisms by which excess adiposity drives greater pH1N1 
infection severity is critical for solving this public health threat.
Similar to humans, obese mice are also more susceptible to influenza infection mortality 
compared with lean controls (8, 9). Several reports have demonstrated that obesity alters 
inflammatory and pathological responses in the lung during influenza infection in mice, but 
the underlying mechanisms causing these aberrant immune responses and ultimately death 
remain unclear (10–15). Excess accumulation of adipose tissue triggers metabolic and 
physiologic perturbations such as insulin resistance, hyperleptinemia, oxidative stress, low-
grade chronic inflammation and alterations in a variety of circulating nutrients and 
hormones, all of which could potentially affect influenza immunity and disease severity (8, 
16).
Although our understanding of host immune responses to influenza virus infection in vitro 
and in vivo are well established, much remains unknown regarding the mechanisms in which 
perturbations in systemic metabolism may impact influenza immune responses and infection 
mortality. This is pertinent because not only is obesity a highly prevalent metabolic disease, 
but other risk factors for severe influenza infections, such as heart disease, diabetes, 
pregnancy and aging (17, 18) are also associated with distinct cellular and systemic 
metabolic complications (16, 19, 20). Metabolic profiling has been useful for identifying 
biomarkers or uncovering complex mechanisms in a number of metabolic diseases such as 
cardiovascular disease, type II diabetes and obesity (21, 22). Further, application of this 
methodology to infectious diseases models continues to gain momentum, facilitating greater 
understanding of the complex interactions between pathogen and host and identifying 
prognostic or diagnostic biomarkers/metabolic signatures unique to certain disease states 
and stages (23–26). Although lipidomics has recently proven useful in identifying lipid 
metabolites that have antiviral effects (27) or serve as influenza biomarkers (28), 
metabolomics has only been applied to a few influenza models in vitro (29, 30) or in vivo 
(26, 31). Relatively little is known regarding the consequences of influenza virus infection 
on the global lung metabolome (at the site of infection) or how altered systemic metabolism 
(e.g. obesity) may impact influenza pathogenesis and metabolic processes in the lung.
In this study we used two models of obesity, diet- and genetic-induced, providing a robust 
characterization of the immunological and metabolic consequences of obesity during pH1N1 
infection. High fat diet (HFD)-induced and genetic-induced obese mice exhibited greater 
pH1N1 mortality, as well as elevated lung inflammatory responses and excess lung damage, 
despite similar viral titers compared with lean control mice. Additionally, both models of 
obesity exhibited distinct alterations in immune cell populations, such as fewer macrophages 
and regulatory T cells (Tregs) in the airways. We also demonstrated that the lung 
metabolome was differentially altered by obesity during influenza virus infection. Further, 
UPLC-MS profiling successfully distinguished urine samples from infected lean and obese 
mice as early as 2 days post infection (dpi), and the urine from infected obese mice reflected 
alterations in a diverse number of metabolic pathways. Pathway enrichment analyses, based 
on the uncovered metabolic signatures in lung tissue and urine, revealed differentially 
regulated metabolic processes that perhaps may be contributing to greater pH1N1 severity in 
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obese mice, such as fatty acid, phospholipid and nucleotide metabolism. Taken together, this 
report provides an in-depth analysis of the immunological and metabolic consequences of 
obesity during influenza virus infection.
Materials and methods
Mice and diets
Diet-induced obesity was achieved by maintaining weanling, male C57BL6/J mice (obtained 
from The Jackson Laboratory, Bar Harbor, ME) on a high fat diet (HFD, 60% kcal fat, 
Research Diets D12492, New Brunswick, NJ), and lean mice were maintained on a low fat 
diet (LFD, 10% kcal fat, Research Diets D12450B) or a standard chow diet (CD, 14% kcal 
fat, ProLab RMH 3000, LabDiet, St. Louis, MO) for 14–16 wks. The HFD and LFD are 
nutritionally defined and contain purified ingredients. The HFD and LFD are nutritionally 
matched except for fat content and carbohydrate content (70% kcal in LFD and 20% kcal in 
HFD provided by carbohydrates). For the CD, calories are derived from 26% protein, 14% 
fat, and 60% carbohydrate.
Genetically-induced obesity was achieved by crossing fully floxed leptin receptor mice on a 
C57BL6/J background (generously provided by Dr. Alyssa Hasty) with C57BL/6J-
Tg(Nkx2-1-cre)2S and/J mice purchased from the Jackson Laboratory. Fully floxed mice 
expressing the Cre transgene under control of the Nkx2.1 promoter (LepRH−/−), lack leptin 
receptor signaling in hypothalamic neurons (LepRH−/−) and become obese due to 
hyperphagia (32). Heterozygous breeding using LepRH+/− and LepRHfl/fl mice was 
necessary since homozygous LepRH−/− mice do not produce offspring (32). Mice were 
genotyped as previously described (32) and housed in isolation cubicles at UNC, which is 
fully accredited by the American Association for Accreditation of Laboratory Animal Care. 
All procedures involving the use of mice were fully approved by the UNC Institutional 
Animal Care and Use Committee.
Influenza virus infection and viral titers
Influenza A/California/04/2009 (BEI Resources, Bethesda, MD) was propagated in 
embryonated hen’s eggs and titered via a modified 50% tissue culture infective dose 
(TCID50) using hemagglutination as an endpoint and evaluated by the method of Reed and 
Muench (33) as previously described (8, 12). Mice were lightly anesthetized via isoflurane 
inhalation and were infected intranasally with 0.05mL of 5.8×102 TCID50 or 1.3×103 
TCID50 as described in Figure Legends. For diet-induced obese mouse models, mice were 
infected at 17–19 wks old. For LepRHfl/fl and LepRH−/− mice were infected at 12–25 wks of 
age (LepRHfl/fl and LepRH−/− were age matched). For influenza viral titers of infected mice, 
bronchoalveolar lavage fluid (BALF) was titered via a modified TCID50 in replicates of 
four.
Serum and BALF measurements
BALF was obtained as previously described (14). ELISA kits were used to measure serum 
leptin (Invitrogen, Carlsbad, CA), triacylglycerol (TAG, Pointe Scientific, Canton, MI), 
insulin (Uppsala, Sweden) and adiponectin (Abcam, Cambridge, UK). Blood glucose was 
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measured via a 6h or 14h fast as described in figure legends. Further, BALF albumin was 
measured with the Mouse Albumin ELISA Kit (Genway Biotech, Inc., San Diego, CA). 
Total protein in BALF was measured via standard BCA assay (BCA kit, Sigma-Aldrich, St 
Louis, MO). BALF cytokines (IL-4, IFN-γ, MCP-1, RANTES, KC, IL-17A, IL-10 and 
TNF-α) were measured using a BioRad Bio-Plex assay (Hercules, CA) per manufacturer’s 
instructions. IL-4 was not measureable above the lower limit of the assay.
Lung Histopathology
The left lobe of the lung was inflated and fixed with 10% neutral buffered formalin. Fixed 
lung tissue was embedded in paraffin and processed for H&E staining by the UNC Animal 
Histopathology Core Facility. The extent of lung immune cell infiltration was scored blindly 
according to a scale from 0 to 4: 0, no inflammation; 1, mild influx of inflammatory cells; 2, 
increased inflammation with ~25–50% of the total lung involved; 3, severe inflammation 
involving 50–75% of the lung; and 4, almost all lung tissue contains inflammatory infiltrate 
(12, 14)
Flow Cytometry
Lung, mediastinal lymph nodes (mLN) and BAL cells were stained for flow cytometry as 
previously described (14). For staining of BAL cells from uninfected mice, BAL samples 
were pooled from 2 individual mice to obtain a sufficient number of cells (2 pooled BAL 
samples represents n=1). The following antibodies were used: CD4 (FITC, PE-Cy7), CD103 
(PE), Foxp3 (APC), Ly6G (FITC), NK1.1 (PE-Cy7) and F4/80 (APC) from eBioscience 
(San Diego, CA) and CD8 (PerCP) and CD3 (APC-Cy7) from BioLegend (San Diego, CA) 
and CD25 (FITC) from BD Biosciences (San Jose, CA). For intracellular staining, all cells 
were fixed and permeabilized using the Foxp3 staining buffer kit (Ebioscience). All samples 
were run on a CyAn ADP Analyzer flow cytometer (Beckman Coulter, Inc., Fullerton, CA) 
and analyzed with FlowJo software (Treestar, Ashland, OR). All cells were analyzed by first 
utilizing a doublet exclusion gate followed by gating of CD3+ T cells for further analysis of 
CD4+ and CD8+ T-cell populations or by gating on CD3− cells for further analysis of 
macrophages (F4/80+), neutrophils (Ly6G+) or NK cells (NK1.1+).
Metabolic Profiling
Lung tissue was harvested and immediately frozen in liquid nitrogen. Urine was collected as 
previously described (25). To every 10 mg of lung tissue 100 μl of 50:50 acetonitrile:water 
was added and the tissue was homogenized using a bead beater operating at 1750 rpm. A 
300 μl sample of lung homogenate was spiked with tryptophan-d5 internal standard, 
lyophilized, reconstituted in 100 μl of 95:5 water:methanol, and 10 μl was injected into a 
SYNAPT G2 QTOF mass spectrometer coupled to an Acquity UPLC (Waters Corporation, 
MA) for broad spectrum metabolomics analysis. The lung metabolites were separated on a 
Waters Acquity BEH HSS T3 column (2.1 × 100mm, 1.8 μm particle size) operating at 50°C 
using a reversed-phase chromatographic method. A gradient mobile phase consisting of 
water with 0.1% formic acid (A) and methanol with 0.1% formic acid (B) were used as 
previously described (34).
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Urine samples (25 μl) were diluted with acetonitrile containing tryptophan-d5 internal 
standard (75 μl). A 5 μl diluted urine was injected into a SYNAPT G2 QTOF mass 
spectrometer coupled to an Acquity UPLC (Waters Corporation, MA) for broad spectrum 
metabolomics analysis. The urine metabolites were separated on a Waters Acquity BEH 
Amide column (2.1 × 150mm, 1.7 μm particle size) operating at 40°C using a HILIC 
chromatographic method. A gradient mobile phase consisting of 10 mM ammonium acetate 
in 95/5 Acetonitrile/H2O with 0.1% Formic Acid (A) and 10 mM ammonium acetate in 
50/50 Acetonitrile/H2O with 0.1% Formic Acid (B) was used under the following 
conditions: 0–1.0 min 1% B, 1.0–12.0 min 100% B, 14.0–15.0 1% B, 15.0–19.0 1% B.
All MS data were collected over 50–1000 m/z in ESI positive and negative ion modes. 
Leucine enkephalin was used as the lock mass and a lock mass scan was collected every 45 
sec and averaged over 3 scans to perform mass correction. Source and desolvation 
temperatures were set at 110 °C and 450 °C, respectively. All MS data analysis (alignment, 
normalization and peak picking) were performed using Progenesis QI (Waters Corporation). 
Multivariate analysis (PCA and OPLS-DA) of the metabolomics data was performed using 
SIMCA (Umetrics, Umea, Sweden) (35). Putative identification of the group differentiating 
metabolites was made using a database search against RTI-RCMRC’s in-house exact-mass-
retention-time library of standards (~500 compounds) and Human Metabolome Data Base 
release version 3.50 (HMDB). Pathway analysis was performed using GeneGO Metacore 
(Thomson Reuters).
Quantitation of lung gene expression
Total RNA was isolated from lung tissue via the TRIzol method (Invitrogen), and reverse 
transcription was performed with Superscript II First Strand Synthesis kit (Invitrogen) and 
oligo (dT) primers. Cytokine and chemokine expression were quantified using qRT-PCR as 
previously described (36). Gene expression levels were normalized to β-actin.
Statistical analysis
For all statistical analyses, JMP Statistical Software (SAS Institute, Cary, NC) or GraphPad 
(San Diego, CA) were used. For parametric data (including metabolites), statistical 
significance was evaluated using a two-way ANOVA or a two-tailed unpaired Student t test. 
Nonparametric data was evaluated using the Wilcoxon signed rank test or Kruskal Wallis 
test. Mean values were considered statistically significant at p≤0.05. The log-rank test was 
used to compare percent survival.
Results
Diet-induced obese mice are more susceptible to pH1N1 mortality compared with CD fed 
and purified LFD fed lean mice
Epidemiological evidence demonstrates that obesity increases the likelihood of severe 
influenza infection complications in humans (17, 37–40), and several mouse models have 
also confirmed this outcome (10–15, 36). Obesity exacerbates lung inflammation and 
pathology, alters lung immune cell populations, impairs lung healing and in some cases 
increases viral titers during influenza infection in mice (10–15, 36). To further investigate 
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the consequences of obesity on pH1N1 immunity, weanling male C57Bl6/J mice were fed a 
purified HFD (60% kcal fat), a purified LFD (10% kcal fat, nutritionally matched to the 
HFD except for fat and carbohydrate content) or a standard CD (14% kcal fat). The two low 
fat control diets (LFD and CD) were included because although previous studies have 
utilized both of these diets as controls for a HFD, they have never been directly compared to 
each other in the same study (10–15, 36). As expected, mice fed a HFD gained significantly 
more weight compared with LFD and CD fed mice (Figure 1A). Although LFD and CD 
mice exhibited relatively similar levels of weight gain in comparison with HFD-induced 
obese mice, LFD mice weighed significantly more than CD mice after 8 wks on the diet. 
Obesity results in metabolic perturbations, reflected by alterations in a number of circulating 
hormones and nutrients (16). In Figure 1B, we demonstrate that HFD fed obese mice had 
elevated fasting blood glucose measures compared with LFD and CD mice. Further, serum 
insulin was elevated in HFD mice compared with CD mice, and LFD mice exhibited a 
relatively intermediate concentration. Additionally, HFD mice had a greater concentration of 
serum triacylglycerol (TAG) and leptin but lower adiponectin levels. In summary, HFD 
mice exhibited prototypical characteristics of obesity, while LFD mice exhibited a 
somewhat intermediate phenotype compared with HFD and CD mice.
After 14–16 wks on the diet, mice were infected with 5.8 × 102 TCID50 of the 2009 
pandemic H1N1 virus, influenza A/Cal/04/09 (pH1N1). Strikingly, while no CD mice 
succumbed to the pH1N1 infection, 40% of LFD mice and more than 80% of HFD mice 
died by 10 dpi (Figure 1C). HFD fed obese mice exhibited a significantly higher mortality 
rate compared with both LFD and CD mice. Although it has been shown that diet-induced 
obese mice are more susceptible to pH1N1 mortality (10), it has never been demonstrated 
that LFD fed mice are also more likely to die from influenza infection compared with CD 
mice. Analysis of absolute weight loss and percent weight loss demonstrated that CD mice 
recover faster from the infection compared with HFD and LFD mice (Figures 1D/E).
Given that all CD mice survived the infection, we next tested if the discrepancy in pH1N1 
mortality between the three dietary groups was maintained with a greater pH1N1 dose. All 
three dietary groups were infected with 1.3 × 103 TCID50, and by 7 dpi, 83% of HFD mice 
died (Figure 1F) compared with 55% of LFD mice and only 33% of CD mice. Despite the 
increased death in all dietary groups compared with the previous lower dose, the mortality 
differences between the dietary groups were relatively maintained in that HFD and LFD 
mice were more susceptible to mortality compared with CD mice (p<0.005, p=0.05 
respectively), and HFD mice trended towards increased mortality compared with LFD mice 
(p=0.08). There were no differences in total weight loss between the three groups (Figure 
1G), but HFD mice displayed a significantly lower percent weight loss over the course of 
the infection compared with LFD and CD mice (Figure 1H), which has been reported 
previously (10). In summary, we show that HFD-induced obesity increases pH1N1 infection 
severity compared with two different lean mouse models. Given that LFD mice exhibited 
greater mortality than CD mice, simply changing the components of a diet (without inducing 
any nutritional deficiencies) can modulate influenza infection severity, and thus we cannot 
rule out synergistic effects of a HFD and obesity.
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Diet-induced obese mice exhibit greater lung damage and inflammation during a pH1N1 
infection
To assess potential mechanisms for the discrepancies in pH1N1 mortality between dietary 
groups, we measured the viral titers in the lung airways of CD, LFD and HFD mice infected 
with 5.8×102 TCID50. There were no differences in viral titers among the three groups at 4 
or 8 dpi (Figure 2A). While some studies report that obesity does not impact influenza titers 
(67,77), it has also been shown that obesity can increase pH1N1 titers (80).
We then assessed the level of cellular infiltration and lung pathology during the pH1N1 
infection. HFD, LFD and CD mice exhibited similar bronchoalveolar lavage (BAL) and 
lung total cell numbers during the infection (Figure 2B/C). As expected, H&E stained lungs 
revealed that pH1N1 infection caused distinct pathological changes in the bronchioles, 
vessels and alveoli of all three dietary groups (Figure 2D). At 4 dpi, partial bronchiole 
denuding and perivascular cuffing occurred in all three dietary groups. By 8 dpi, 
perivascular cuffing, bronchial denuding and immune cell infiltration increased in all three 
dietary groups compared with the day 4 time point. Histopathology scores of total lung 
infiltration revealed there were no significant differences among the three dietary groups 
(data not shown), consistent with similar total BAL and lung cell numbers.
To assess the level of damage to the alveolar-endothelial barrier, total protein and albumin 
were measured in BALF from pH1N1 infected CD, LFD and HFD mice (Figure 2E/F). At 4 
dpi, HFD mice exhibited a greater fold increase in BALF protein compared with LFD and 
CD mice (Figure 2E). Further, at 8 dpi, HFD mice displayed a greater fold increase in BALF 
protein compared with CD mice. Additionally, HFD mice exhibited a greater fold increase 
in BALF albumin compared with LFD and CD mice at 4 dpi (Figure 2F). Therefore, obesity 
enhances lung epithelial cell injury during pH1N1 infection despite no differences in viral 
burden or total leukocyte recruitment.
Cytokine and chemokine production in the lung airways of the three dietary groups was also 
measured via a multiplex assay to assess inflammatory responses (Figure 2G). HFD mice 
had elevated levels of the keratinocyte chemoattractant (KC or CXCL1) and MCP-1 
compared with LFD and CD mice at 8 dpi. TNF-α was greater in HFD and CD mice at 8dpi 
compared with LFD mice. There were no differences in IFN-γ, IL-10, IL-17A or RANTES. 
Taken together, despite no differences in lung inflammatory cell infiltration and viral titers, 
HFD mice exhibited greater lung injury and production of inflammatory cytokines during 
pH1N1 infection.
HFD-induced obese mice have fewer macrophages and Tregs in the lung airways 
compared with lean mice
In order to gain a better understanding of the causes and consequences of greater lung injury 
and alterations in chemokine expression in HFD mice, the distribution of innate immune 
cells in the airways of pH1N1 infected CD, LFD and HFD mice was assessed. Figure 3A is 
a representative flow cytometry histogram for identification of macrophages, neutrophils 
and natural killer (NK) cells. Figure 3B represents the percentages (top) and numbers 
(bottom) of F4/80+ macrophages, NK1.1+ NK cells and Ly6G+ neutrophils. Unexpectedly, 
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HFD mice had significantly fewer BAL macrophages at 4 dpi, trending fewer NK cell 
number (p=0.07), and similar numbers of neutrophils with CD mice. Although HFD mice 
had greater levels of KC and MCP-1 expression (neutrophil and macrophage chemokines, 
respectively), this did not result in greater infiltration of macrophages or neutrophils.
We then measured the distribution of CD4+ and CD8+ T cells in the BAL, lung and mLN of 
the three dietary groups. HFD mice had fewer BAL CD4+ T cells at 8 dpi with no 
differences in CD8+ T cell numbers compared with CD mice (Figure 3C/D). Given the 
alterations in T cell numbers detected in the lung airways, CD4+ and CD8+ T cell numbers 
were measured in lung tissue and in mLN at 4 and 8 dpi. There were no differences in lung 
or mLN T cell numbers between CD and HFD mice (data not shown).
CD4+Foxp3+ Tregs have been shown to curtail inflammatory responses to RSV and some 
influenza infection models in mice (41–43). Because we detected fewer BAL CD4+ T cells 
in HFD mice, we also suspected fewer BAL Treg cells as well, perhaps contributing to 
heightened lung inflammation and damage in HFD mice. Figure 3E is a representative 
gating scheme for identification of BAL Tregs in CD, LFD and HFD mice. HFD mice had a 
significantly greater percentage of Tregs at 4 dpi (Figure 3E), and consistent with fewer 
CD4+ T cells at 8 dpi, HFD mice had fewer Tregs at 8 dpi (Figure 3F). Additionally, the 
level of Treg activation via CD103 expression was measured (44), and HFD mice had fewer 
CD103+ BAL Tregs as well (Figure 3G). Given the discrepancy in Treg number in the lung 
airways, Treg distribution in lung tissue and mLN were also assessed (Figure 3H/I). HFD 
mice had fewer Tregs at 0 and 4 dpi in the lung tissue and fewer at 8 dpi in the mLN 
compared with LFD mice.
Metabolic profiling distinguishes lung samples from uninfected and infected obese mice
Obesity is inherently a metabolic disease, and metabolic profiling has found widespread 
usage in infectious disease models for identifying biomarkers and improving our 
understanding of these complex diseases (23–26). Therefore, we hypothesized that 
metabolic profiling would not only provide a snapshot of the metabolic consequences of 
obesity in the lung during pH1N1 infection, but would also shed light on potential 
mechanisms driving greater pH1N1 severity in obese mice. Lungs were harvested from CD, 
LFD and HFD mice at 0, 4, and 8 dpi, and UPLC-MS metabolic profiling was performed. In 
Figure 4A, the orthogonal partial least squares discriminant analysis (OPLS-DA) plot shows 
significant separation between lung samples from uninfected CD and HFD mice. As one 
might expect, several metabolites were altered by the HFD and/or obesity, and a majority of 
these metabolites were related to lipid metabolism (involved in fatty, cholesterol or 
phospholipid metabolic pathways). Once infected, the HFD and CD lung metabolic profiles 
continued to separate (Figure 4B). An increase in differential metabolites was observed in 
HFD infected mice at 4 dpi, particularly in phospholipid and nucleotide metabolites (Figure 
4B).
By 8 dpi, the number of metabolites significantly altered by obesity more than doubled 
compared with uninfected lung tissue (Figure 4C). Fatty acid and phospholipid related 
species comprised a majority of significantly altered metabolites in HFD mice at 8 dpi. 
Further several amino acid and ketone metabolites were detected at high levels in the lungs 
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(with (S)-3-hydroxybutyric acid detected at a 17.5x greater concentration in lungs of HFD 
mice, p<0.0005). Few of the differentially altered metabolites in uninfected HFD mice were 
also different at 8 dpi, indicating that the detected metabolic changes occurring in the lung 
during infection are not simply due to obesity or HFD feeding, but are a consequence of the 
infection in the HFD-induced obese mice.
Lastly, we determined if the unique metabolic changes that were measured in the lungs of 
HFD mice at 8 dpi may provide a snapshot of some of the altered dynamic metabolic 
processes occurring during the infection. We utilized the GeneGo Metacore systems biology 
software to uncover differentially altered metabolic pathways (Figure 4D). The most 
significantly altered pathway in the lungs of obese mice at 8 dpi was N-Acyltransferase 
metabolism (p<0.0005), as well as a number of fatty acid-related pathways and nucleotide 
metabolism pathways (Figure 4D). For metabolite comparisons, we primarily focused on 
differences between CD and HFD mice as we detected the greatest discrepancy in infection 
severity between these two groups. However, a complete list of differentially altered 
metabolites between CD, LFD and HFD mice as well as fold change and p-values are listed 
in Supplemental Table 1.
Obesity, independent of diet, increases pH1N1 mortality
HFD mice exhibited greater pH1N1 infection severity, alterations in inflammatory immune 
responses and diverse changes in lung metabolism during the infection. However, a 
limitation of utilizing a diet model of obesity is that differential outcomes between lean (CD 
or LFD) and HFD obese mice could be influenced by differences in the diets, potentially 
confounding the effects of obesity. Further, LFD mice display greater mortality compared 
with CD mice, suggesting that simply modulating the diet (without causing any nutritional 
deficiencies) can impact pH1N1 infection outcome, although not to the same extent as in 
HFD obese mice. Therefore, we included a genetic model of obesity to assess the impact of 
obesity on infection responses independent of dietary effects.
We utilized a genetic model of obesity in which excess adiposity is driven primarily by 
hyperphagia (all mice are fed a CD). It has previously been shown that ob/ob mice, a robust 
model of genetic obesity, are more susceptible to pH1N1 infection compared with wild type 
mice (10). However, utilization of the ob/ob mouse model has a number of limitations due to 
the global deficiency of leptin signaling. Leptin is critical for proper physiology and 
immunity, and leptin deficiency has been shown to impair host defenses, thus, confounding 
the immunomodulatory consequences of obesity (8). Therefore, we used a tissue-specific 
model, previously characterized by Ring et al., in which disruption of leptin signaling is 
limited to hypothalamic neurons (the primary site of leptin-mediated appetite control) (32) 
to further address the impact of obesity on pH1N1 immunity. These mice become rapidly 
obese and exhibit hyperinsulinemia, hyperglycemia and hyperleptinemia among other 
metabolic alterations characteristic of obesity (32).
Male (Figure 5A) and female (Figure 5B) LepRH−/− mice, lacking functional leptin 
signaling in hypothalamic neurons, rapidly gained excess body weight compared to lean 
LepRHfl/fl and LepRH+/− mice. At 13–16 wks of age, LepRH−/−, LepRH+/−, and LepRHfl/fl 
mice were infected with 5.8 × 102 TCID50 pH1N1. Strikingly, obese male (Figure 5C) and 
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female LepRH−/− (Figure 5D) mice were significantly more susceptible to pH1N1 mortality 
compared with lean LepRH+/− and LepRHfl/fl mice. Obese, LepRH−/−, mice lost more 
absolute weight during the pH1N1 infection compared with both lean groups (Figure 5E/F). 
Obese male and female LepRH−/− mice displayed a lower percentage of body weight lost 
compared with lean mice, this is likely due to the greater pre-infection weight of LepRH−/− 
mice (Figure 5G/H). There was no significant difference detected in percent mortality 
between male and female LepRH−/− mice; therefore, for further analyses, male and female 
mice were combined. Additionally, the mortality curve from HFD mice was not 
significantly different from either male or female LepRH−/− mice (data not shown).
Obese LepRH−/− mice exhibit greater lung inflammatory responses and alterations in lung 
immune cell populations during pH1N1 infection
Given the elevated mortality in the LepRH−/− obese mice compared with lean controls, we 
next assessed pathological and immunological responses in the lungs of LepRH−/− mice. 
Figure 6A demonstrates that while LepRH−/− mice had significantly larger mesenteric white 
adipose depots (mWAT) and livers compared with lean LepRHfl/fl mice, there were no 
differences in lung weight. Lung viral titers were then measured, and LepRH−/− did not 
exhibit differences in viral burden (Figure 6B). However, the obese LepRH−/− mice did have 
fewer infiltrating cells into the airways during the infection (Figure 6C), but exhibited a 
greater level of injury to the lung epithelium compared with lean LepRHfl/fl mice at 8 dpi 
(Figure 6D). Gene expression of lung cytokines and chemokines also demonstrated that the 
genetically obese mice had greater pulmonary inflammation at 8 dpi (Figure 6E). LepRH−/− 
mice exhibited higher levels of IL-10, MCP-1 and KC at 8 dpi.
In the dietary model of obesity, HFD mice had fewer BAL macrophages and Tregs. 
Therefore, the distribution of these cells in LepRHfl/fl and LepRH−/− mice was assessed at 4 
and 8 dpi (Figure 6F–H). Similar to HFD obese mice, LepRH−/− mice had fewer BAL 
macrophages (Figure 6F). Additionally, LepRH−/− mice also had fewer CD4+ T cells, CD8+ 
T cells (data not shown), BAL Tregs and activated BAL Tregs (Figure 6G/H). Therefore, 
both HFD and LepRH−/− obese mice exhibit similar differences in BAL macrophage and 
Treg numbers during pH1N1 infection in comparison with lean controls.
Obese LepRH−/− mice exhibit distinct metabolic perturbations in lung tissue during pH1N1 
infection
To enhance our analysis of the metabolic consequences of obesity during pH1N1 infection, 
the lungs of LepRHfl/fl and LepRH−/− mice were harvested at 0 and 8 dpi and processed for 
metabolic profiling. In Figures 7A–B, the OPLS-DA plots demonstrate significant 
separation between lung samples from uninfected and infected LepRHfl/fl and LepRH−/− 
mice. LepRH−/− mice exhibited alterations in a number of lipid metabolites at both 0 and 8 
dpi. Additionally, few metabolites differentially affected by obesity at 0 dpi were also 
different at 8 dpi, indicating the recovered metabolic data at 8 dpi are specific to the 
consequences of obesity during pH1N1 infection, rather than caused by obesity alone. Of 
interest, a majority of metabolites different between LepRHfl/fl and LepRH−/− mice, were 
lower in the lungs of LepRH−/− mice. A pathway enrichment analysis based on the 8 dpi 
lung metabolomes of LepRHfl/fl and LepRH−/− mice was constructed. Similar to pathways 
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altered in the lungs of HFD mice, a number of the pathways altered in obese LeprH−/− mice 
were related to nucleotide or fatty acid metabolism as well as amino acid metabolism 
(Figure 7C).
Metabolic profiling of urine can differentiate lean LepRHfl/fl mice and obese LepRH−/− at an 
early pH1N1 infection time point
We have previously demonstrated that 1H-nuclear magnetic resonance-based metabolic 
profiling of urine can distinguish lean and obese mice infected with a sublethal dose of 
influenza A/Puerto Rico/8/1934 (H1N1) (26). Urinary profiling is both informative and 
readily translatable given that urine reflects a wide range of physiological and 
pathophysiological processes and is easily obtained in clinical settings (compared with 
tissues). We therefore sought to extend our metabolic analysis to include profiling of urine 
from uninfected and pH1N1 infected LepRHfl/fl and LeprH−/− mice. During the infection, we 
chose to profile urinary samples at 2 dpi. This time point occurs prior to drastic weight loss 
or obvious signs of sickness, allowing utilization of metabolic profiling for identifying 
biomarkers that may be used to predict or explain mechanisms of greater severity in 
LepRH−/− obese mice. The PLS-DA plot in Figure 8A demonstrates that UPLC-MS 
profiling was able to successfully distinguish urine from LepRHfl/fl and LepRH−/− mice at 0 
and 2 dpi. A relatively large number of metabolites were detected at greater levels in the 
urine at 0 dpi in LepRH−/− mice (Figure 8B). At 2 dpi, several unique metabolites were 
altered by infection in obese mice such as L-Acetylcarnitine, phosphatidylcholine and 8 
different amino acid-related metabolites (Figure 8C). Lastly, pathway analysis of urine 
metabolomes at 2 dpi, revealed alterations in pathways related to fatty acid, amino acid and 
histamine metabolism (Figure 8D). Although it is known that obesity is characterized by 
alterations in fatty acid metabolism, we show for the first time that changes in fatty acid 
metabolic pathways (and several other pathways) occur systemically in the urine and locally 
in the lung during a pH1N1 infection.
Discussion
Obesity is a global epidemic, and the consequences of excess adiposity are diverse and 
continue to mount (45). Following the emergence of the 2009 pH1N1 strain, obesity was 
reported to be an independent risk factor for greater pH1N1 (17, 37–40) and seasonal (46–
48) influenza infection severity. In this study, we provide an in-depth analysis of the 
immunologic and metabolic complications associated with obesity during infection with the 
2009 pH1N1 influenza. Previous studies in mice have shown that obesity alters lung wound 
healing and inflammatory responses during a pH1N1 infection (10), possibly due to 
hyperleptinemia (11). However, the complications of obesity are complex, and a number of 
other factors could be affecting pH1N1 immunity such as: hyperglycemia, hyperinsulinemia, 
oxidative stress, changes in the gut microbiome, and alterations in cellular and systemic 
metabolism (9). Therefore we sought to combine immunological assessments with 
metabolomics to provide a more global characterization of the metabolic consequences of 
obesity on pH1N1 infection.
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One of several mechanisms in which HFD-induced obesity may result in greater pH1N1 
severity is the impact of consuming a high fat diet. Altering dietary composition, even 
without inducing nutritional deficiencies, can have systemic metabolic consequences (49–
51) and can affect antiviral immunity (52). One inherent limitation with a diet-induced 
obesity model, is a high fat diet will always differ from a lean control diet (e.g. saturated 
fatty acid content, carbohydrate content etc.), potentially confounding the implications of the 
impact of obesity. One goal of this investigation was to provide an in-depth analysis of the 
consequences of HFD-induced obesity in comparison with two different lean control groups 
to better assess dietary contributions. It has previously been demonstrated that LFDs high in 
sucrose can have metabolic consequences and can impact immune responses (53). 
Additionally, the CD differs in nearly every aspect from the purified LFD and HFDs (yet is 
still one of the most widely used control diets for obesity studies) (54). Several key differing 
components are amounts of phytoestrogens and dietary fiber. Chow diets are primarily 
derived from plant constituents, and therefore contain phytoestrogens as well as dietary fiber 
(54). Phytoestrogens have been shown to affect metabolism and behavior. Further, fiber can 
also impact metabolic health and modulate the gut microbiome (54, 55), and the purified 
LFD has no fiber (perhaps contributing to greater weight gain and a somewhat intermediate 
metabolic phenotype between CD mice and HFD mice as in Figure 1). These differing 
characteristics of the diets likely explain some of the differential responses observed 
between the three dietary groups (especially between LFD and CD mice).
Currently, three studies have demonstrated that diet-induced obese mice exhibit greater 
mortality to a primary pH1N1 infection (10, 11, 15). Two of these studies used a CD for the 
lean control group and a 45% or 60% kcal HFD for obese mice (10, 11), and one study used 
a 60% kcal HFD compared with a nutrient matched, purified, 10% kcal low fat diet (15). 
Although we found HFD mice were more susceptible compared with both lean groups, lean 
LFD mice exhibited greater mortality compared with lean CD mice. This demonstrates that 
modulating the diet alone, without inducing obesity, can increase pH1N1 severity, and it is 
possible there are synergistic effects of being obese and consuming a HFD. This outcome 
may have potential public health implications in that perhaps not only being obese increases 
risk for influenza severity, but the composition of the diet one chooses to eat could also 
impact severity as well.
Given the complications of diet-induced obesity models, a genetic model of obesity was also 
included in our analysis in attempt to better assess the immunological consequences of 
excess adiposity independent of dietary effects. Obese, male and female LepRH−/− mice 
were significantly more susceptible to pH1N1 mortality compared with lean control groups. 
Ob/ob mice lacking the hormone leptin are a commonly used model of genetically-induced 
obesity, in which lack of leptin satiety cues result in hyperphagia and obesity (56, 57). 
O’Brien et al. has previously demonstrated that ob/ob obese mice were more susceptible to 
pH1N1 mortality (10). Although this is informative and helps to address the complications 
of dietary models discussed above, a global deficiency of leptin signaling can cause 
physiologic and immunologic complications, confounding the effects of obesity (57). 
Therefore, we utilized a genetic model of obesity in which disruption of leptin signaling is 
isolated to hypothalamic neurons (although there is some evidence of Nkx2.1 expression in 
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the lungs, esophagus and during development (221)). This genetic model of obesity 
established that although diet may synergize with obesity to impact pH1N1 immunity, 
obesity alone is sufficient to increase pH1N1 mortality. Additionally, this study highlights 
the importance of careful consideration in choosing a mouse model of obesity (genetic- vs 
diet-induced), and in selecting proper dietary controls for HFD-induced obesity studies.
Both diet- and genetic-induced obese mice exhibited greater lung damage during the pH1N1 
infection. This excess lung pathology has been demonstrated previously in obese mice, and 
is likely due to impaired wound healing in the lung (10). A number of potential mechanisms 
may be responsible for enhanced lung damage in obese mice. Tregs are critical regulators of 
immunopathology and have been shown to limit inflammatory responses to RSV and some 
influenza infection models in mice (41–43) We have previously demonstrated that obese 
mice have fewer Tregs in the lung airways during a secondary pH1N1 challenge, and Tregs 
isolated from obese mice exhibited impaired suppressive capacity compared with Tregs 
isolated from lean mice (14). Therefore, we also investigated the distribution of Tregs in the 
lung, lung airways and mLN during a primary pH1N1 infection. At 8 dpi, HFD- and 
genetic-induced obese mice had fewer BAL Tregs and fewer activated BAL Tregs. It is 
currently unclear why obese mice have fewer BAL Tregs during influenza infection, but it is 
well established that obesity results in a deficiency of Tregs in metabolic tissues such as the 
liver and white adipose tissue (8, 9). Obesity results in greater lung damage during both 
primary and secondary pH1N1 infections, and therefore uncovering how obesity modulates 
BAL Treg responses is likely important for understanding the complex mechanisms of 
influenza severity caused by an obese state.
Additionally, fewer F4/80+ macrophages were detected in the lung airways of obese mice at 
4 dpi in HFD mice and at 8 dpi in LepRH−/− mice. NK cell numbers were also slightly lower 
in HFD mice compared with CD mice, but this did not reach statistical significance 
(p=0.07). Macrophages fulfill a diverse number of processes in infection recovery such as 
propagating inflammatory responses or promoting wound healing (16, 58). For example, 
alternatively activated macrophages are prototypically anti-inflammatory and facilitate 
wound healing (16). Although we did not phenotype BAL macrophages, perhaps obese mice 
had fewer BAL alternatively activated macrophages during infection, contributing to greater 
immunopathology. Future investigations are necessary to assess how obesity modulates 
macrophage polarization and function in the lung during pH1N1 infection.
Obesity is inherently a metabolic disease. Therefore, we hypothesized that metabolic 
profiling can be used to enhance our current understanding of the consequences of obesity 
on influenza infection. A partial least square discriminant analysis of the broad spectrum 
metabolomics data successfully distinguished lung samples on the basis of both obesity and 
infection status. In lung tissue from uninfected and infected HFD mice, several lipid species 
related to fatty acid, cholesterol or phospholipid metabolism were altered compared with CD 
mice. Of interest, the number of lipid metabolites altered in HFD lungs nearly tripled by 8 
dpi, with some lipid metabolites such as 3-Oxododecanoic acid and 4-Hydroxyisovaleric 
acid detected at nearly 10-fold greater concentrations. Obesity is associated with greater 
levels of circulating unesterified fatty acids and TAG (8), but why these lipid metabolites are 
altered in the lungs of obese mice at 8 dpi (rather than in uninfected mice or at 4 dpi) is 
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unknown. Perhaps the complex milieu of excess inflammatory cytokines and metabolic 
hormones in the lungs of obese mice impacts cellular metabolism, ultimately impeding 
proper lung healing and recovery.
Metabolic profiling of lung tissue revealed several interesting findings. P-cresol sulfate was 
detected at a 5-fold greater concentration in uninfected HFD-obese mice compared with CD 
mice. By 4 dpi, p-cresol sulfate was detected at a 55-fold greater level in the lungs of HFD-
obese mice, and remained elevated at 8 dpi with HFD mice showing greater than 10x p-
cresol sulfate levels. P-cresol sulfate is a metabolite derived from secondary metabolism of 
p-cresol by gut microbiota, typically reported to be found in the urine (59). P-cresol sulfate 
accumulates during conditions of kidney failure, and some evidence indicates it may be 
toxic (59, 60) and can impact immune cell function (61). Although, we did not measure 
urinary p-cresol sulfate in HFD mice, perhaps elevated levels of this metabolite may reflect 
impaired kidney function. Additionally, given that P-cresol sulfate is a microbial derived 
metabolite, it is also possible that influenza differentially alters gut microbiota function in 
obese mice, ultimately impacting antiviral immune responses. It has previously been 
demonstrated that altering the gut microbiome can affect influenza infection immunity in 
mice (62). Of interest, LFD mice also exhibited greater concentrations of lung p-cresol 
sulfate compared with CD mice, suggesting that perhaps elevated p-cresol sulfate levels are 
due to dietary-microbiome interactions. There is little known regarding p-cresol sulfate in 
the lung or during the context of an infection, but the strikingly elevated levels detected in 
the lungs of HFD mice merit further investigation.
A number of other metabolites notably elevated in the lungs of HFD mice include glutamyl-
proline (increased in HFD mice at 4 and 8 dpi), tetrahydrocotisol (4 dpi), 3-hydroxybutric 
acid (8 dpi) and the numerous acyl-carnitine species elevated at 8 dpi in HFD lungs. Chronic 
overnutrion is thought to increase cytosolic lipid content in insulin-sensitive tissues (such as 
liver and skeletal muscle), which can ultimately impair insulin signaling (63). Perhaps the 
elevated levels of acyl-carnitines reflect these processes in the lung. Further, accumulation 
of acyl-carnitines may indicate impaired fatty acid oxidation in lung cells (63). Taken 
together, the diverse changes in the lung metabolome of HFD mice during pH1N1 may 
reflect pathological processes contributing to greater infection severity.
LepRH−/− mice also exhibited alterations in an array of lung metabolites prior to and during 
the pH1N1 infection. One notable difference between HFD-obese mice and LepRH−/− obese 
mice was that most differentially altered metabolites in HFD mice were elevated compared 
to CD mice, whereas most metabolites in LepRH−/− mice were detected at a lower 
concentration compared with LepRHfl/fl mice. Further, relatively few metabolites were 
similarly altered in both obesity models. At 8 dpi, only arachidonic acid and 
hydroxyvalerylcarnitine were elevated in the lungs of both HFD and LepRH−/− mice 
compared with lean controls. Of interest, arachidonic acid is a substrate for eicosanoid 
metabolism, and arachidonic acid metabolites (such as leukotrienes and prostaglandins) can 
impact inflammatory responses (64). The fact that the lung metabolomes in HFD and 
LepRH−/− mice differ greatly, highlights the impact of the diet in this model. Future studies 
are required to better understand the synergistic effects of a HFD and excess adiposity, and 
how these factors interact to modulate the lung metabolome and affect pH1N1 immunity.
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We also performed metabolic profiling on urine samples from LepRHfl/fl and LepRH−/− mice 
at 2 dpi. Similar to changes in lung metabolites, alterations in urinary metabolites related to 
fatty acid, nucleotide and amino acid metabolism were measured. The fact that metabolic 
profiling can distinguish LepRH−/− mice from lean control mice as early as 2 dpi (prior to 
any obvious signs of illness or drastic weight loss), introduces the possibility of utilizing 
metabolic profiling to compliment current prognostic or diagnostic approaches in the future. 
Additionally, the urinary metabolome may provide insight into the mechanisms in which 
obesity increases pH1N1 mortality. For example, taurine was elevated in the urine of obese 
LepRH−/− mice at 2 dpi. Detection of taurine has been reported to be increased under 
conditions of oxidative stress (65). The fold change of taurine increased from slightly 
greater in uninfected urine of LepRH−/− mice to 4-fold greater by 2 dpi. Therefore, this may 
indicate that influenza infection induces greater oxidative stress in obese mice.
Taken together, we have provided the first analysis of both the immunologic and metabolic 
consequences of obesity during pH1N1 infection. It is likely that the distinct metabolic 
perturbations detected in the lungs of obese mice are both reflective and inflictive of 
pathologic changes occurring in the lung following infection. In addition, we were able to 
document distinct changes in the urine of infected mice before overt signs of illness, 
demonstrating the strength of this approach. Future studies are required to further integrate 
this metabolomic data with immunologic responses to identify novel mechanisms for greater 
pH1N1 severity in obese mice.
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HFD-induced obesity increases pH1N1 morbidity and mortality. A, Weanling, male, 
C57BL6/J mice were randomly placed on a high fat (HFD, 60% kcal fat), low fat (LFD, 
10% kcal fat) or chow diet (CD 14% kcal fat) for 14 wks (n>30). B, Mice were fasted 
overnight and blood glucose was measured (n=8) as well as non-fasted serum insulin, TAG, 
adiponectin, and leptin (n=6–7). C, After 14–16 wks of dietary exposure, mice were infected 
intranasally with 5.8 ×102 TCID50 pH1N1 and monitored for death (n≥21). D/E, Absolute 
weight loss (D) and percent weight loss (E) normalized to day 0, pre-infection weight over 
the course of the pH1N1 infection (n≥21). F, After 14–15 wks of dietary exposure, mice 
were infected with 1.3×103 TCID50 and mortality was monitored (n=12). G/H, Absolute 
weight loss (G) and percent weight loss normalized to day 0, pre-infection weight (H) over 
the course of the 1.3×103 TCID50 pH1N1 infection (n=12). Each bar or data point represents 
mean ± SEM. *p<0.05, **p<0.005, ***p<0.0005 comparing HFD with LFD and CD mice, 
and #p<0.05 ##p<0.005 comparing LFD and HFD mice.
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HFD mice exhibit greater pH1N1 lung damage and inflammation. A, BALF viral titers after 
5.8×102 TCID50 pH1N1 infection (n=4 for uninfected mice and n=7–8 at 4 and 8 dpi). B/C, 
Total number of BAL cells (B) and lung cells (C, n≥8). D, H&E stained lung pathology 
slides (n=6–8). Each pathology image represents a 40x magnification of the designated area 
shown in the 4x magnified image in the top right of each field. E/F, Fold increase of BALF 
protein (E, n=6–10) and BALF albumin (F, n=5–7) during the pH1N1 infection. Fold 
increase normalized to uninfected mice within each dietary group. G, Fold change of BALF 
cytokine concentrations between CD, LFD and HFD mice determined from a multiplex 
assay (n=5–8). Each bar or data point represents mean ± SEM. *p<0.05, **p<0.005 
comparing HFD with CD mice, ^p<0.05 comparing HFD with LFD mice, and #p<0.05 
comparing CD with LFD mice.
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HFD-induced obese mice have fewer BAL macrophages and Tregs during pH1N1 infection. 
A, Representative flow cytometry histograms of BAL macrophages, NK cells and 
neutrophils of CD, LFD and HFD mice at 4 dpi following a 5.8×102 TCID50 pH1N1 
infection. Fluorescence minus one (FMO) staining controls are shaded solid grey. B, 
Percentage (top) and total number (bottom) of BAL F4/80+ cells, NK1.1+ cells and Ly6G+ 
cells (n=5–8). Percentage represents of total CD3neg cells. C–D, Number of BAL CD4+ (C) 
and CD8+ T cells (D). E, Representative Treg flow cytometry gating scheme. F–G, Number 
of BAL Tregs (F) and activated Tregs (G). H–I, Number of Lung Tregs (H) and mLN Tregs 
(I). For BAL cells n=3 of two pooled mice at day 0 and n=5–8 at 4 and 8 dpi. For mLN and 
lung cells, n=5–10. Each bar represents mean ± SEM. *p<0.05, **p<0.005, ***p<0.0005.
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HFD-induced obesity alters lung metabolic pathways during pH1N1 infection. A–C, OPLS-
DA plot and differentially altered metabolites of lung samples from uninfected (A), 4 dpi 
(B) and 8 dpi (C) CD and HFD mice (n=5–6). Next to each metabolite, *p<0.05, **p<0.005, 
***p<0.0005, and numbers in parentheses represent the number of species for that 
metabolite that are significantly different between HFD and LFD (i.e. methodology was not 
able to differentiate the multiple species). D, Pathway enrichment analysis generated in 
GeneGo of metabolic pathways significantly different between CD and HFD mice at 8 dpi. 
ChREBP, carbohydrate-responsive element-binding protein; HETE, 
hydroxyeicosatetraenoic acid; HPETE, hydroperoxyeicosatetraenoic acid.
Milner et al. Page 23














Genetically obese, LepRH−/− mice, are more susceptible to pH1N1 mortality compared with 
lean LepRHfl/fl mice. A–B, Weight gain of male (A) and female (B) mice lacking leptin 
receptor signaling in hypothalamic neurons LepRH−/−, heterozygous mice LepRH+/− and 
fully floxed LepRHfl/fl mice (n≥9). C–D, Mortality curves for male (C) and female (D) mice 
after infection with 5.8×102 TCID50 pH1N1 at 14–16 wk of age (n≥9). E–F, Total weight 
loss for male (E) and female (F) mice after pH1N1 infection (n≥9). G–H, Percent weight 
loss for male (G) and female (H) mice after pH1N1 infection (n≥9. Each data point 
represents mean ± SEM. *p<0.05, **p<0.005, ***p<0.0005. In Figures A–F, *p<0.05, 
**p<0.005 or ***p<0.0005 comparing LepRH−/− with both LepRH−/− and LepRH+/− mice. 
For Figures G–H, **p<0.05 or ***p<0.0005 comparing LepRH−/− with LepRHfl/fl mice and 
#p<0.05 or ##p<0.005 comparing LepRH−/− with LepRH+/− mice.
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Obese LepRH−/− mice exhibit greater pH1N1 lung damage and inflammation. A, Mean 
weight of mesenteric white adipose tissue, liver and lungs of LepRHfl/fl and LepRH−/− mice 
prior to infection (n=7–10). B, BALF viral titers following a 5.8×102 TCID50 pH1N1 
infection (n=5–8). C, Total number of BAL cells during infection (at 0 dpi, n=4–5 from two 
pooled samples and at 4 and 8 dpi, n= 6–7). D, Fold increase in total BALF protein levels. 
Fold increase normalized to uninfected mice within each dietary group (n=6–8). E, Fold 
change in gene expression of lung cytokines and chemokines (n=4–6). F–H, Number of 
BAL CD3−F4/80+ macrophages (F), CD4+ T cells (G), Tregs and activated Tregs (H, at 0 
dpi, n=4–5 from two pooled samples and at 4/8 dpi, n= 6–7). Each bar represents mean ± 
SEM. *p<0.05, **p<0.005, ***p<0.0005.
Milner et al. Page 25














Metabolic profiling reveals alterations in distinct metabolic networks in lungs of pH1N1 
infected LepRH−/− obese mice. A–B, OPLS-DA plot and differentially altered metabolites of 
lung samples from uninfected (A) and 8 dpi (B) LepRHfl/fl and LepRH−/− mice (n=5–6). C, 
Pathway analysis generated in GeneGo of all pathways significantly different from lung 
tissue of LepRHfl/fl and LepRH−/− mice at 8 dpi. Next to each metabolite, *p<0.05, 
**p<0.005, ***p<0.0005. PDGF, platelet-derived growth factor; RXR, retinoid X receptor; 
PPAR, peroxisome proliferator-activated receptor; RAR, retinoic acid receptor; VDR, 
vitamin D receptor; PEDF, pigment epithelium-derived factor.
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Metabolic profiling reveals alterations in distinct metabolic networks in urine of pH1N1 
infected obese LepRH−/− mice. A, OPLS-DA plot from urine samples from the same cohort 
of uninfected and 2 dpi infected mice. B–C, Differentially altered metabolites in the urine of 
uninfected (B) and at 2 dpi (C) LepRH−/− mice compared with lean LepRHfl/fl mice (n=3). 
D, Pathway analysis generated in GeneGo of all pathways significantly different at 2 dpi 
between LepRHfl/fl and LepRH−/− mice. Next to each metabolite, *p<0.05, **p<0.005, 
***p<0.0005. # represents 1-Nitro-7-glutathionyl-8-hydroxy-7,8-dihydronapthalene. 
PPARγ, peroxisome proliferator-activated receptor γ.
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